Skip to main content
Caplight Logo









Brain Navi Biotechnology

Brain Navi Biotechnology

Private
TaiwanHealthcare & Life Scienceshttps://brainnavi.com/

Last Round

Private Equity

Jul 1, 2025

Est. Valuation

$50M

Total Funding Raised

$320,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Brain Navi Biotechnology is a medical technology company that designs and develops robotic surgical navigation systems for neurosurgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

neurosurgical robotsurgical navigationrobotic surgerymedical roboticsneurosurgerysurgical AIcomputer visionneuro-endoscopesurgical automationrobotic surgery platformmedical devicedeep brain stimulationsurgical biopsymedtechsurgical tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Brain Navi Biotechnology Comparables

Compare Brain Navi Biotechnology with similar companies based on industry and business-model similarity.

Brain Navi Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
华科精准(北京)医疗设备股份有限公司
86%
北京柏惠维康科技股份有限公司
84%
Huake Precision (Beijing) Medical Technology Co., Ltd.
84%

Brain Navi Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJul 1, 2025
AcceleratorMar 17, 2024

Key People

Founding team and executive leadership

Jerry Chen

CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 137% MoM.

  • May 14, 2026

    Monthly visitors grew 52% MoM, reaching 1.3K.

Brain Navi Biotechnology Filings

Explore SEC and related filing metadata, where available.

Brain Navi Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Brain Navi Biotechnology's valuation, stock price, and market status.

Is Brain Navi Biotechnology a public or private company?

Brain Navi Biotechnology is a private company.

What is the current stock price of Brain Navi Biotechnology?

Brain Navi Biotechnology is a private company with no public stock price. No recent secondary market data is available.

How much is Brain Navi Biotechnology worth (valuation)?

Brain Navi Biotechnology's valuation is estimated at $50.0M based on funding round data.

Can I buy Brain Navi Biotechnology stock?

Brain Navi Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Brain Navi Biotechnology's last funding round?

Brain Navi Biotechnology's most recent funding round was Private Equity on July 1, 2025.

Who are the main investors in Brain Navi Biotechnology?

Investor information for Brain Navi Biotechnology is not publicly disclosed.

Will Brain Navi Biotechnology IPO soon?

No public IPO plans have been announced for Brain Navi Biotechnology.

How can I track Brain Navi Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Brain Navi Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTaiwan
Employee Range13
Year Founded2015
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?